Patent US4604404A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4604404A Expired / Lapsed US ⏱️ 0.0 years remaining

Antiviral sulfonated naphthalene formaldehyde condensation polymers

Assignee: AH Robins Co Inc
•
Filing: 1985-04-03
•
Granted: 1986-08-05
•
Expires: 2005-04-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method is disclosed for combating Herpes simplex viruses, Types I and II, which comprises topically applying and antiviral arylsulfonic acid polymer to the animal tissue under attack. Bacterial infections are also affectively treated.

Inventors

  • 👤 Harry R. Munson, Jr.
  • 👤 Robert W. Tankersley, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 22:25
CPC Classifications
A; A61; A61Q; A61Q17/00; A61Q17/005; A61K; A61K31/00; A61K31/74; A61K31/795; A61K8/00; A61K8/18; A61K8/72; A61K8/84; A61Q11/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 195 words
A method of treating viral infections caused by Type I or Type II Herpes simplex viruses comprising topically administering to infected tissue of a living animal under attack by said virus an effective amount of an arylsulfonic acid polymer having a repeating unit selected from the group consisting of the following structures: ##STR2## wherein R 1 and R 2 are selected from the group consisting of hydrogen, alkyl having 1 to 20 carbon atoms, alkoxy having 1 to 20 carbon atoms, fluorine, chlorine and bromine; R 3 is hydrogen, alkoxy having 1 to 20 carbon atoms; X is selected from the group consisting of a direct covalent bond between the aromatic rings, a loweralkylene having 1 to 5 carbon atoms, a lower alkylene having 2 to 5 carbon atoms, oxygen, sulfur, and --O(CH 2 ) n O-- wherein n is an integer from 2 to 20; p is from about 0.4 to about 1.2; the sum of q and r is from about 0.8 to about 2.4; and M is selected from the group consisting of lithium, sodium, potassium, calcium, magnesium, zinc, aluminum, hydrogen, ammonium and substituted ammonium ions derived from pharmaceutically acceptable organic amines.
Claim 2
Independent Claim 195 words
A method of treating viral infections caused by Type I or Type II Herpes simplex viruses comprising topically administering to infected tissue of a living animal under attack by said virus an effective amount of an arylsulfonic acid polymer having a repeating unit selected from the group consisting of the following structures: ##STR2## wherein R 1 and R 2 are selected from the group consisting of hydrogen, alkyl having 1 to 20 carbon atoms, alkoxy having 1 to 20 carbon atoms, fluorine, chlorine and bromine; R 3 is hydrogen, alkoxy having 1 to 20 carbon atoms; X is selected from the group consisting of a direct covalent bond between the aromatic rings, a loweralkylene having 1 to 5 carbon atoms, a lower alkylene having 2 to 5 carbon atoms, oxygen, sulfur, and --O(CH 2 ) n O-- wherein n is an integer from 2 to 20; p is from about 0.4 to about 1.2; the sum of q and r is from about 0.8 to about 2.4; and M is selected from the group consisting of lithium, sodium, potassium, calcium, magnesium, zinc, aluminum, hydrogen, ammonium and substituted ammonium ions derived from pharmaceutically acceptable organic amines.
Claim 3
Dependent Claim 20 words
The method of claim 1 wherein said arylsulfonic acid polymer is a condensation polymer of an arylsulfonic acid with formaldehyde.
Claim 4
Dependent Claim 14 words
The method according to claim 2 wherein said arylsulfonic acid is naphthelene sulfonic acid.
Claim 5
Dependent Claim 21 words
The method according to claim 3 wherein said sulfonic acid groups are in the form of a sodium or zinc salt.
Claim 6
Dependent Claim 14 words
The method of claim 1 wherein said viral infection causes venereal disease in humans.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-08-04 1990-02-03 1990-08-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-08-04 1994-02-03 1994-08-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-08-04 1998-02-03 1998-08-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag